FDA
approval
· 2012-09-20
FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)
Summary
The FDA approved a supplemental application for PROLIA (denosumab) submitted by Amgen, Inc. This approval updates PROLIA's labeling or indications as part of a …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PROLIA (DENOSUMAB)